Newsletter | July 18, 2019

07.18.19 -- Advancements In How Future Therapeutics Are Discovered And Commercialized

The Value Of Digital In Biopharma

By working together across the biopharma industry, digital technology can be leveraged and data science can reengineer key elements of the drug manufacturing process to ease commercial scale-up.

How Biogen Integrated PAT With End-To-End Supply Chain Transparency

Amgen's Digital Transformation: Linking Raw Material Data From Suppliers To Patients

Your Strategy To Manufacture, No Longer A One-Size-Fits-All

The traditional method of big batch manufacturing must change as companies move away from the one-size-fits-all blockbuster model toward more innovative, targeted biologics that deliver better outcomes.

Doubling Up For Speed: Using Parallel Operations In Biopharma Manufacturing

Translating Biopharma Knowledge To Cell And Gene Therapies

Streamlining, connecting, and automating workflows to shape the future of cellular treatment delivery has the potential to transform how we treat and potentially cure once life-threatening diseases.

Cell Therapy Manufacturing Under GMP: How And When To Get Started

Cost Of Healthcare And Biopharma Implications

The pharmaceutical industry’s success has become something of a double-edged sword, and our healthcare systems are burdened with the costs of lifestyle challenges. Everyday businesses and healthcare professionals must work diligently to improve our quality of life, but pricing and access will continue to be a battle globally that the industry must take note of.

Why Invest In Emerging Markets Now